Literature DB >> 21508396

The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer.

Arta Strazdina1, Gaida Krumina, Maris Sperga.   

Abstract

UNLABELLED: The aim of our study was to evaluate the diagnostic value of contrast-enhanced ultrasonography (CEUS) in comparision to morphological examinations of radical prostatectomy specimens and to study factors limiting the visibility of malignant lesions. PATIENTS AND METHODS: Fifty patients with proven prostate cancer (PV) were examined transrectally using, grey-scale, power Doppler (PD) and CEUS (pulse-inversion mode, low mechanical index) shortly before prostatectomy. The results were compared with morphological findings. The influence of tumour size, localization and grade on tumour visibility was studied.
RESULTS: A total of 72 prostate cancer foci were found at pathologic evaluation. Grey-scale imaging demonstrated 34 (47.2%), power Doppler 37 (51.4%) and CEUS 44 (61.1%) of these foci. No lesion less than 1 cm in size was detected. Statistically significant correlation was established between the visibility of of tumour in CEUS and the size of a focus (r=0.610, p=0.001). Sensitivity of CEUS in detection of peripheral gland tumours was 63.3%, of lesions invading both peripheral and central gland 83.3%, and of centrally located tumours 27.8%. In comparision, sensitivity of grey-scale imaging was 53.3%, 70.8% and 5.6%, respectively. CEUS detected 35.5% of low-grade and 80% of intermediate-grade tumours; the corresponding results of grey-scale imaging were 16.1% and 70%, respectively. Statistically significant correlation was detected (r=0.459: p=0.001) between visualization capabilities of CEUS and the malignant grade of prostate cancer.
CONCLUSION: CEUS improves prostate cancer detection. Sensitivity of CEUS is lower in cases of small low-grade tumours, centrally located lesions and large infiltrating prostate tumours.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508396

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Image-guided robotic interventions for prostate cancer.

Authors:  Ashwin N Sridhar; Archie Hughes-Hallett; Erik K Mayer; Philip J Pratt; Philip J Edwards; Guang-Zhong Yang; Ara W Darzi; Justin A Vale
Journal:  Nat Rev Urol       Date:  2013-06-18       Impact factor: 14.432

Review 2.  Irreversible Electroporation for the Ablation of Prostate Cancer.

Authors:  Andreas Karagiannis; John Varkarakis
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

Review 3.  Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer.

Authors:  Yushan Liu; Shi Zeng; Ran Xu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

4.  Applications of transrectal ultrasound in prostate cancer.

Authors:  C J Harvey; J Pilcher; J Richenberg; U Patel; F Frauscher
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

5.  Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.

Authors:  Dong Ryul Jang; Dae Chul Jung; Young Taik Oh; Songmi Noh; Kyunghwa Han; Kiwook Kim; Koon-Ho Rha; Young Deuk Choi; Sung Joon Hong
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 6.  The utility and limitations of contrast-enhanced ultrasound for the diagnosis and treatment of prostate cancer.

Authors:  Futoshi Sano; Hiroji Uemura
Journal:  Sensors (Basel)       Date:  2015-02-27       Impact factor: 3.576

7.  Contrast-enhanced ultrasound evaluation of pancreatic cancer xenografts in nude mice after irradiation with sub-threshold focused ultrasound for tumor ablation.

Authors:  Yi Hui Gao; Lei Wu; Rui Wang; Qian Guo; Yi Ni Chen; Bing Hu; Li Xin Jiang
Journal:  Oncotarget       Date:  2017-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.